What is the most important information I should know about Adipost (phendimetrazine)?
Weight loss during pregnancy can harm an unborn baby, even if you are overweight. Do not use phendimetrazine if you are pregnant.
Phendimetrazine may cause blurred vision or impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.
Phendimetrazine may be habit-forming and should be used only by the person for whom it was prescribed. Keep the medication in a secure place where others cannot get to it.
Do not stop using phendimetrazine suddenly after long-term use, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using phendimetrazine.
Do not crush, chew, break, or open the extended-release capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time.
What other drugs will affect Adipost (phendimetrazine)?
Tell your doctor about all other medicines you use, especially:
insulin or oral diabetes medications;
certain blood pressure medications, such as doxazosin (Cardura), prazosin (Minipress), or terazosin (Hytrin); or
any other diet pills.
This list is not complete and other drugs may interact with phendimetrazine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
For the Consumer
Applies to phendimetrazine: oral capsule, oral capsule extended release, oral tablet
Along with its needed effects, phendimetrazine (the active ingredient contained in Adipost) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking phendimetrazine:Rare
- Seeing, hearing, or feeling things that are not there
- severe mental changes
- burning while urinating
- chest pain or discomfort
- decreased ability to exercise
- difficult or painful urination
- dry mouth
- fast, irregular, pounding, or racing heartbeat or pulse
- feeling of warmth
- increased need to urinate
- numbness or tingling in the arms or legs
- pain or discomfort in the arms, jaw, back, or neck
- passing urine more often
- redness of the face, neck, arms, and occasionally, upper chest
- shakiness in the legs, arms, hands, or feet
- shortness of breath
- swelling of the feet or lower legs
- trembling or shaking of the hands or feet
- trouble with breathing
- trouble with sleeping
- trouble with thinking, speaking, or walking
Get emergency help immediately if any of the following symptoms of overdose occur while taking phendimetrazine:Symptoms of overdose
- Abdominal or stomach cramps
- blurred vision
- change in consciousness
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- fast, slow, or irregular heartbeat
- feeling sad or empty
- lack of appetite
- loss of consciousness
- loss of interest or pleasure
- overactive reflexes
- physical attempt to injure
- pounding in the ears
- rapid breathing
- trouble with concentrating
- unusual tiredness or weakness
- violent actions
Some side effects of phendimetrazine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:Incidence not known
- Decreased interest in sexual intercourse
- difficulty having a bowel movement (stool)
- inability to have or keep an erection
- increased in sexual ability, desire, drive, or performance
- increased interest in sexual intercourse
- loss in sexual ability, desire, drive, or performance
- stomach pain
- unable to sleep
Renal Dose Adjustments
Data not available; Use with caution.
-Extended-release: Safety and efficacy have not been established in patients younger than 17 years.
-Immediate-release: Safety and efficacy have not been established in patients younger than 12 years.
Consult WARNINGS section for additional precautions.
US Controlled Substance: Schedule III
Data not available